Martha L. Lepow

4.5k total citations
110 papers, 3.2k citations indexed

About

Martha L. Lepow is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Martha L. Lepow has authored 110 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 30 papers in Infectious Diseases and 28 papers in Microbiology. Recurrent topics in Martha L. Lepow's work include Pneumonia and Respiratory Infections (30 papers), Bacterial Infections and Vaccines (27 papers) and Respiratory viral infections research (21 papers). Martha L. Lepow is often cited by papers focused on Pneumonia and Respiratory Infections (30 papers), Bacterial Infections and Vaccines (27 papers) and Respiratory viral infections research (21 papers). Martha L. Lepow collaborates with scholars based in United States, Greece and Germany. Martha L. Lepow's co-authors include Irving Goldschneider, E C Gotschlich, Martin F. Randolph, Ronald Gold, Frederick C. Robbins, R. Gold, Joel S. Samuelson, Richard A. Venezia, Marilyn Kacica and Robert J. Warren and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Martha L. Lepow

105 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha L. Lepow United States 31 2.0k 1.3k 731 326 312 110 3.2k
Birger Trollfors Sweden 39 3.2k 1.6× 2.3k 1.8× 1.3k 1.7× 328 1.0× 116 0.4× 200 5.4k
Calvin C. Linnemann United States 36 2.1k 1.0× 493 0.4× 1.2k 1.7× 451 1.4× 85 0.3× 95 3.6k
P. Helena Mäkelä Finland 35 2.1k 1.1× 1.5k 1.2× 558 0.8× 752 2.3× 159 0.5× 69 5.0k
Edward A. Mortimer United States 28 874 0.4× 455 0.4× 668 0.9× 127 0.4× 84 0.3× 95 2.4k
James P. Luby United States 29 1.8k 0.9× 227 0.2× 1.1k 1.6× 255 0.8× 127 0.4× 90 3.1k
Ruth B. Kundsin United States 24 685 0.3× 725 0.6× 288 0.4× 245 0.8× 58 0.2× 84 2.1k
Raija Vainionpää Finland 35 2.7k 1.3× 366 0.3× 1.2k 1.6× 452 1.4× 456 1.5× 99 3.7k
Carmen Muñoz‐Almagro Spain 29 2.2k 1.1× 744 0.6× 720 1.0× 221 0.7× 336 1.1× 204 3.3k
Marta Luisa Ciofi degli Atti Italy 35 2.4k 1.2× 1.2k 1.0× 787 1.1× 157 0.5× 158 0.5× 183 4.0k
Markus Knuf Germany 34 3.0k 1.5× 1.3k 1.0× 759 1.0× 494 1.5× 129 0.4× 139 3.9k

Countries citing papers authored by Martha L. Lepow

Since Specialization
Citations

This map shows the geographic impact of Martha L. Lepow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha L. Lepow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha L. Lepow more than expected).

Fields of papers citing papers by Martha L. Lepow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha L. Lepow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha L. Lepow. The network helps show where Martha L. Lepow may publish in the future.

Co-authorship network of co-authors of Martha L. Lepow

This figure shows the co-authorship network connecting the top 25 collaborators of Martha L. Lepow. A scholar is included among the top collaborators of Martha L. Lepow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha L. Lepow. Martha L. Lepow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lepow, Martha L., et al.. (2003). Meningococcal immunology. Immunology and Allergy Clinics of North America. 23(4). 769–786. 6 indexed citations
2.
Abzug, Mark J., Gretchen Cloud, John S. Bradley, et al.. (2003). Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. The Pediatric Infectious Disease Journal. 22(4). 335–340. 77 indexed citations
3.
Abzug, Mark J., Gretchen A. Cloud, John L. Bradley, et al.. (2003). . The Pediatric Infectious Disease Journal. 22(4). 335–340. 3 indexed citations
4.
Kacica, Marilyn, et al.. (1995). Measles antibodies in women and infants in the vaccine era.. Journal of Medical Virology. 45(2). 227–229. 26 indexed citations
5.
Kacica, Marilyn, Michael J. Horgan, Karen E. Preston, Martha L. Lepow, & Richard A. Venezia. (1994). Relatedness of Coagulase-Negative Staphylococci Causing Bacteremia in Low-Birthweight Infants. Infection Control and Hospital Epidemiology. 15(10). 658–662. 23 indexed citations
6.
LaRussa, Philip, et al.. (1994). Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction. The Journal of Pediatrics. 124(6). 932–935. 23 indexed citations
7.
Plotkin, Scott R., James G. Easton, N. A. Halsey, et al.. (1992). Chemotherapy for tuberculosis in infants and children. PEDIATRICS. 89(1). 161–165. 37 indexed citations
8.
Peter, G., James G. Easton, N. A. Halsey, et al.. (1991). Haemophilus influenzae type b conjugate vaccines: Recommendations for immunization of infants and children 2 months of age and older: Update. PEDIATRICS. 88(1). 169–172. 25 indexed citations
9.
Plotkin, Stanley A., N. A. Halsey, Martha L. Lepow, et al.. (1990). Parvovirus, erythema infectiosum, and pregnancy. PEDIATRICS. 85(1). 131–133. 19 indexed citations
10.
Plotkin, S. A., Robert S. Daum, G. Scott Giebink, et al.. (1989). Measles: Reassessment of the current immunization policy. PEDIATRICS. 84(6). 1110–1113. 70 indexed citations
11.
Plotkin, S. A., Robert S. Daum, G. Scott Giebink, et al.. (1989). Haemophilus influenzae type b conjugate vaccines: Update. PEDIATRICS. 84(2). 386–387. 8 indexed citations
12.
Lascari, André D. & Martha L. Lepow. (1989). . The Journal of Pediatrics. 114(1). 108–108. 3 indexed citations
13.
Plotkin, S. A., Robert S. Daum, G. Scott Giebink, et al.. (1988). Haemophilus influenzae type b conjugate vaccine. PEDIATRICS. 81(6). 908–911. 18 indexed citations
15.
Wade, Nancy A., Martha L. Lepow, James Veazey, & Hilaire J. Meuwissen. (1985). Progressive Varicella in Three Patients with Wiskott-Aldrich Syndrome: Treatment with Adenine Arabinoside. PEDIATRICS. 75(4). 672–675. 10 indexed citations
16.
Lepow, Martha L.. (1978). Enteroviral meningitis: A reappraisal.. PubMed. 62(2). 267–9. 8 indexed citations
17.
Ballow, Mark, G S Incefy, Robert A. Good, Savita Pahwa, & Martha L. Lepow. (1977). SEVERE COMBINED IMMUNODEFICIENCY WITH B LYMPHOCYTES, ANTIBODY SYNTHESIS AND RESPONSE TO ALLOGENEIC CELLS IN MLC. Pediatric Research. 11(4). 484–484. 3 indexed citations
18.
Lepow, Martha L. & Ronald Gold. (1974). Current status of vaccines against the meningococcus. Preventive Medicine. 3(4). 449–455. 1 indexed citations
19.
Woods, Wilna A., et al.. (1966). Immunofluorescent Studies on Rubella-Infected Tissue Cultures and Human Tissues. The Journal of Immunology. 96(2). 253–260. 33 indexed citations
20.
Lepow, Martha L., David H. Carver, Harry T. Wright, Wilna A. Woods, & Frederick C. Robbins. (1962). A Clinical, Epidemiologic and Laboratory Investigation of Aseptic Meningitis during the Four-Year Period, 1955–1958. New England Journal of Medicine. 266(23). 1181–1187. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026